![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/adam_scragg_head_of_export_controls_sanctions_group_ethics_compliance_johnson_matthey_uk.png?itok=GUQ__Uz3&c=46f460373f0cd3140c5d44ec0be23fd3)
Adam Scragg
Head of Export Controls & Sanctions, Group Ethics & Compliance
Johnson Matthey (UK)
![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/1516898407615.jpg?itok=HTupjOSe&c=294b9a6f2ad4a6ada27f79d28e7ff00d)
Justin Fallon
Co-Founder
Bolden Therapeutics
![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/1609777738391.jpg?itok=tAfkLq1r&c=294b9a6f2ad4a6ada27f79d28e7ff00d)
Sudhir Agrawal
Founder and President
Arnay Sciences
![](https://connectedhealthandfitness.com/sites/default/files/styles/panopoly_image_square/public/speakers/5s6a9799ma_0.jpg?itok=fXqPmclf&c=786052673c095278afbbc7dce211ca0e)
Martin Akerman
CTO
Envisagenics
Dr. Martin Akerman is the Co-founder and CTO of Envisagenics. He is the inventor of SpliceCore®, Envisagenics’ flagship platform born of his vision of applying machine learning to RNA information and discovering new drug targets in areas of unmet need. Martin trained as a post doctorate fellow with Dr. Adrian Krainer at Cold Spring Harbor Laboratory, where he helped in the development of Spinraza®, the first FDA-approved RNA therapeutic for treating Spinal Muscular Atrophy. He received his PhD in Bioinformatics from Technion, Israel Institute of Technology, where he studied how RNA splicing can boost functionality of the human genome and trigger diseases.